Protective efficacy of a novel simian adenovirus vaccine against lethal MERS-CoV challenge in a transgenic human DPP4 mouse model

Middle East Respiratory Syndrome

(2017) Yaseen M. Arabi et al.   NEW ENGLAND JOURNAL OF MEDICINE

ChAdOx1 and MVA based vaccine candidates against MERS-CoV elicit neutralising antibodies and cellular immune responses in mice

(2017) Naif Khalaf Alharbi et al.   VACCINE

High Prevalence of Middle East Respiratory Coronavirus in Young Dromedary Camels in Jordan

(2017) Neeltje van Doremalen et al.   VECTOR-BORNE AND ZOONOTIC DISEASES

Viral vectors as vaccine platforms: from immunogenicity to impact

(2016) Katie J Ewer et al.   CURRENT OPINION IN IMMUNOLOGY

A roadmap for MERS-CoV research and product development: report from a World Health Organization consultation

(2016) Kayvon Modjarrad et al.   NATURE MEDICINE

SARS and MERS: recent insights into emerging coronaviruses

(2016) Emmie de Wit et al.   NATURE REVIEWS MICROBIOLOGY

Chimpanzee Adenovirus Vaccine Provides Multispecies Protection against Rift Valley Fever

(2016) George M. Warimwe et al.   Scientific Reports

Characterization and Demonstration of the Value of a Lethal Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease

(2015) Xinrong Tao et al.   JOURNAL OF VIROLOGY

Generation of a Transgenic Mouse Model of Middle East Respiratory Syndrome Coronavirus Infection and Disease

(2015) Anurodh Shankar Agrawal et al.   JOURNAL OF VIROLOGY

2014 MERS-CoV Outbreak in Jeddah — A Link to Health Care Facilities

(2015) Ikwo K. Oboho et al.   NEW ENGLAND JOURNAL OF MEDICINE

Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study

(2013) Chantal BEM Reusken et al.   LANCET INFECTIOUS DISEASES

Middle East respiratory syndrome coronavirus (MERS-CoV) causes transient lower respiratory tract infection in rhesus macaques

(2013) E. de Wit et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity

(2012) Matthew D. J. Dicks et al.   PLoS One